166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials
⬇️
artículo científico publicado el 1 de octubre de 2003
5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis
artículo científico publicado en 2009
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia
artículo científico publicado en 1999
A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma
A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center.
artículo científico publicado en 2017
A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease
scientific article published on 01 September 1996
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors
artículo científico publicado en 2000
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma
artículo científico publicado en 2002
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.
artículo científico publicado en 2012
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells
artículo científico publicado en 2010
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation
artículo científico publicado en 1998
A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy
artículo científico publicado en 2012
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
artículo científico publicado en 2019
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts
artículo científico publicado en 2006
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
artículo científico publicado en 2020
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation
artículo científico publicado en 2000
A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis
artículo científico publicado en 2004
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease
artículo científico publicado en 2009
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy
⬇️
artículo científico publicado el 1 de diciembre de 1997
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid
artículo científico publicado en 2011
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results
artículo científico publicado en 2017
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
artículo científico publicado en 2013
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas
artículo científico
A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia
artículo científico publicado en 1992
A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.
artículo científico publicado en 2016
AML-loaded DC generate Th1-type cellular immune responses in vitro
artículo científico publicado en 2006
AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemia
artículo científico publicado en 1984
Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation
artículo científico publicado en 1986
Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation
artículo científico publicado en 1985
Accelerated therapeutic progress in diffuse large B cell lymphoma
artículo científico
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies
artículo científico publicado en 2014
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
artículo científico publicado en 2004
Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
artículo científico publicado en 2004
Acute graft-vs.-host disease and interstitial pneumonitis interrelated problems following allogeneic bone marrow transplantation: effects of intravenous immune globulin and other interventions
artículo científico publicado en 1988
Acute lymphoblastic leukemia: recent advances in biology and therapy.
artículo científico
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia
artículo científico publicado en 1993
Acute myelogenous leukemia: recent advances in therapy
artículo científico publicado en 1987
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study
scientific article published on 01 January 2000
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience
artículo científico publicado en 2013
Adenovirus infections in adult recipients of blood and marrow transplants
artículo científico publicado en 2001
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy
artículo científico publicado en 2012
Adult stem cells and tissue repair
artículo científico publicado en 2003
Adverse effects of molgramostim in marrow transplant recipients
artículo científico publicado en 1993
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation
artículo científico publicado en 2015
Age is a prognostic factor for the overall survival of multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation
artículo científico publicado en 2019
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.
artículo científico publicado en 2017
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
scientific article published on 01 October 2018
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2018
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
artículo científico publicado en 2019
Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia
artículo científico publicado en 2016
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease
artículo científico publicado en 1997
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience
artículo científico publicado en 1999
Allogeneic blood stem cell transplantation in advanced hematologic cancers
artículo científico publicado en 1997
Allogeneic blood stem cell transplantation: considerations for donors
⬇️
artículo científico publicado el 1 de agosto de 1997
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease
artículo científico publicado en 1995
Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase
artículo científico publicado en 1982
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
artículo científico
Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry
artículo científico publicado el 1 de enero de 1992
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia
⬇️
artículo científico publicado el 24 de marzo de 1984
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age
⬇️
artículo científico publicado el 17 de febrero de 2011
Allogeneic haematopoietic transplantation for Richter's syndrome
scientific article published on 01 September 2000
Allogeneic hematopoietic cell transplantation for metastatic breast cancer
artículo científico publicado en 2007
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
artículo científico publicado en 2006
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
artículo científico publicado en 2017
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes
artículo científico
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
artículo científico publicado en 2007
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study
artículo científico publicado en 2013
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy
artículo científico publicado en 1999
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect
artículo científico publicado en 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens
artículo científico publicado en 2000
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy
scientific article published on 01 November 1999
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases
artículo científico publicado en 1998
Allogeneic peripheral blood progenitor cell transplantation in solid tumors
artículo científico publicado en 1999
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors
artículo científico publicado en 1996
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer
scientific article published on 01 March 1998
Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis
artículo científico publicado en 2014
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
scientific article published on 01 May 2000
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy
artículo científico publicado en 2014
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors
artículo científico publicado en 2011
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation
artículo científico publicado en 2010
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
artículo científico publicado en 2006
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease
artículo científico publicado en 2000
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution
artículo científico publicado en 2015
Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission
artículo científico publicado en 2017
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus
scientific article published on 01 December 1996
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients
artículo científico publicado el 1 de agosto de 1997
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia
artículo científico publicado en 2004
Allogenic bone marrow transplantation in chronic lymphocytic leukemia
artículo científico publicado en 1996
Allotransplants for patients 65 years or older with high-risk acute myeloid leukemia
article
Altered gene expression in busulfan-resistant human myeloid leukemia
artículo científico publicado en 2008
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma
artículo científico publicado en 2018
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection
artículo científico publicado en 2012
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation
artículo científico publicado en 2004
Analysis of Chimerism Following Allogeneic Bone Marrow Transplantation by Fluorescent-in-Situ Hybridization
⬇️
artículo científico publicado el 1 de mayo de 1997
Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid
artículo científico
Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation
artículo científico publicado en 1999
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.
artículo científico publicado en 2013
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia
⬇️
artículo científico publicado el 1 de octubre de 1983
Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial
artículo científico publicado en 1983
Aplastic Anemia: Biology and Treatment
artículo científico publicado el 1 de octubre de 1981
Are 2 cords better than 1?
artículo científico publicado en 2007
Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
artículo científico publicado en 2015
Are some cases of acute leukemia with t(8;21) hybrid leukemias?
artículo científico publicado en 1990
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial
artículo científico publicado en 2008
Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China.
artículo científico publicado en 2016
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation
artículo científico publicado en 2011
Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up
artículo científico publicado en 2014
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients
artículo científico publicado en 2015
Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research
artículo científico publicado en 2012
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement
artículo científico publicado en 2015
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
artículo científico publicado en 2009
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
artículo científico publicado en 2012
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma
scientific article published on 29 January 2007
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
artículo científico publicado en 2015
Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients
scientific article published on 02 October 2020
B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?
scientific article published on 01 October 1993
BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.
artículo científico publicado en 1994
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size
artículo científico publicado en 2012
Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia
scientific article published on 01 September 1994
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone
artículo científico publicado en 1991
Better allele-level matching improves transplant-related mortality after double cord blood transplantation.
artículo científico publicado en 2015
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.
artículo científico publicado en 2014
Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals
artículo científico publicado en 1996
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges
artículo científico publicado en 2007
Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor
artículo científico publicado en 2013
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
artículo científico publicado en 2009
Blood and marrow transplantation compensation: perspective in payer and provider relations
artículo científico publicado en 2004
Blood stem cell procurement: donor safety issues.
artículo científico publicado en 1998
Blood stem cell transplantation in older patients
artículo científico publicado en 2009
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)
scientific article published on 01 June 2000
Bone marrow aplasia associated with proliferation of large granular lymphocytes and subsequent transformation to acute lymphoblastic leukemia
artículo científico publicado en 1989
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation
artículo científico publicado en 2014
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma
scientific article published on 01 January 1997
Bone marrow transplantation after the Chernobyl nuclear accident
scientific article published on 01 July 1989
Bone marrow transplantation for Fanconi anemia.
artículo científico publicado en 1995
Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies
artículo científico publicado en 1987
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.
artículo científico publicado en 1988
Bone marrow transplantation for severe aplastic anemia
artículo científico publicado en 1991
Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy
artículo científico publicado en 1990
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
artículo científico publicado en 2007
Bone marrow transplantation for severe aplastic anemia: has outcome improved?
artículo científico publicado en 1997
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome
⬇️
artículo científico publicado el 1 de enero de 1992
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia
artículo científico publicado en 2002
Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease
⬇️
artículo científico publicado el 1 de marzo de 1984
Bone marrow transplantation from unrelated donors.
artículo científico publicado en 1996
Bone marrow transplantation in acute leukaemia
artículo científico publicado en 1986
Bone marrow transplantation in chronic myelogenous leukemia
artículo científico publicado en 1988
Bone marrow transplantation in patients with leukaemia previously transfused with blood products from family members
artículo científico publicado en 1987
Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure
scientific article published on 01 August 1990
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
artículo científico publicado en 1996
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors
Bone-marrow transplantation for chronic myelogenous leukaemia
scientific article published on 01 December 1985
Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients
scientific article published on 01 May 2000
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM
scientific article published on 01 October 2020
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia
artículo científico publicado en 2002
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
artículo científico publicado en 2018
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans
artículo científico publicado en 2003
CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields
artículo científico
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study
artículo científico publicado en 2004
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
artículo científico publicado en 1995
Can Treg therapy prevent GVHD?
scientific article published on 01 January 2011
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?
artículo científico publicado en 2014
Can we cure refractory Hodgkin's lymphoma with transplantation?
artículo científico publicado en 2020
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma
artículo científico publicado en 1999
Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment
scientific article published on 01 October 1984
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
artículo científico publicado en 2007
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2014
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy
artículo científico publicado en 1997
Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma).
artículo científico publicado en 2018
Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s
⬇️
artículo científico publicado el 5 de agosto de 1992
Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia
artículo científico publicado en 2014
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer
scientific article published on 01 November 1998
Chemotherapy versus transplants for acute myelogenous leukemia in second remission
artículo científico publicado en 1996
Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunity
artículo científico publicado en 2012
Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials
artículo científico publicado en 2013
Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma
artículo científico publicado en 2014
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
artículo científico publicado en 2001
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
artículo científico publicado en 2002
Chronic leukemias: oncogenes, chromosomes, and advances in therapy
artículo científico publicado en 1986
Chronic myelogenous leukemia: recent advances
artículo científico
Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study
artículo científico publicado en 2016
Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.
artículo científico publicado en 2017
Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience
artículo científico
Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients
⬇️
artículo científico publicado en 2019
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood
artículo científico publicado en 2013
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation
artículo científico publicado en 2006
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
artículo científico publicado en 2004
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures
artículo científico publicado en 1996
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results
artículo científico publicado en 2016
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2012
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
scientific article published on 11 October 2010
Collection of peripheral blood stem cells from normal donors 60 years of age or older
artículo científico publicado en 1997
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells
artículo científico publicado en 2017
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients
artículo científico publicado en 1995
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.
artículo científico publicado en 2010
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults
scientific article published on 01 June 1998
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
artículo científico publicado en 1996
Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience
artículo científico publicado en 2001
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
scientific article published on 01 May 2020
Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment
artículo científico publicado en 2004
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens
scientific article published on 11 January 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study
artículo científico publicado en 2019
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients
artículo científico publicado en 2002
Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis
artículo científico publicado en 1997
Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma
artículo científico publicado en 2004
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts
artículo científico publicado en 2015
Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators
artículo científico publicado en 2015
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
artículo científico publicado en 2001
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2015
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue
artículo científico publicado en 1997
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas
artículo científico publicado en 2005
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study
artículo científico publicado en 2002
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial
scientific article published on 22 March 2019
Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes
artículo científico publicado en 2007
Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients
artículo científico publicado en 2000
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors
artículo científico publicado en 2001
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients
artículo científico publicado en 1988
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.
artículo científico publicado en 2017
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.
artículo científico publicado en 2010
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
artículo científico publicado en 2012
Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation
scientific article published on 01 December 2000
Curative potential of hematopoietic stem cell transplantation for advanced psoriasis
scientific article published on 03 April 2019
Current approaches to management of infections in bone marrow transplants
artículo científico publicado en 1989
Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemia.
artículo científico publicado en 2003
Cutaneous manifestations of chronic graft-versus-host disease
artículo científico publicado en 2006
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.
artículo científico publicado en 1993
Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission
artículo científico publicado en 2013
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia
artículo científico publicado en 2020
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning
artículo científico publicado en 2017
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.
artículo científico publicado en 2014
Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy
artículo científico publicado en 2020
Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study
artículo científico publicado en 1999
Cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation
scientific article published on January 1990
Cytomegalovirus infections after allogeneic bone marrow transplantation
artículo científico publicado en 1990
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients
artículo científico publicado en 2001
Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells
artículo científico publicado en 2002
Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.
artículo científico publicado en 2002
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
artículo científico publicado en 2000
Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hemaptopoietic Stem Cell Transplantation
artículo científico publicado en 2022
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system
artículo científico publicado en 1999
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study
artículo científico publicado en 2001
Delay of Alternative Antiviral Therapy and Poor Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Recipients of Allogeneic Stem Cell Transplant.
artículo científico publicado en 2018
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
artículo científico publicado en 1996
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing
artículo científico publicado en 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant
scientific article published on 16 July 2007
Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses
artículo científico publicado en 1999
Designed transfer of specific immune responses with bone marrow transplantation
artículo científico publicado en 1986
Designing an ethical policy for bone marrow donation by minors and others lacking capacity
artículo científico publicado en 2004
Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab
artículo científico publicado en 2010
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy
artículo científico publicado en 2013
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation
artículo científico publicado el 1 de diciembre de 1992
Development and validation of a risk assessment tool for BKPyV Replication in Allogeneic Stem cell Transplant Recipients
scientific article published on 30 June 2020
Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy
scientific article published on 24 August 2016
Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia
artículo científico publicado en 2016
Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor
artículo científico publicado en 2002
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia
scientific article published on 01 July 2005
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
artículo científico publicado en 2008
Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies
artículo científico publicado en 2011
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
artículo científico publicado en 1997
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center
artículo científico publicado en 2012
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response
artículo científico publicado en 2004
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis
artículo científico publicado en 2001
Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies
artículo científico publicado en 2012
Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
artículo científico publicado en 2017
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease
artículo científico publicado en 2009
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation
artículo científico publicado en 2011
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study
artículo científico publicado en 2012
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
scientific article published on 20 May 2016
Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
artículo científico publicado en 2006
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.
artículo científico publicado en 2015
Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units
artículo científico publicado en 2002
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis
scientific article published on July 2010
Durable remission with salvage second autotransplants in patients with multiple myeloma
artículo científico publicado en 2011
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant
artículo científico publicado en 2012
Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome
artículo científico publicado en 2014
Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation
scientific article published on 01 June 1996
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia
artículo científico publicado en 2018
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia
scientific article published on 01 May 2000
Early myeloablative therapy for multiple myeloma.
artículo científico publicado en 1994
Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery
scientific article published on 01 January 1998
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis
artículo científico publicado en 2011
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis
artículo científico publicado en 2010
Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study
artículo científico publicado en 1993
Effect of long-term storage in TRIzol on microarray-based gene expression profiling
artículo científico publicado en 2010
Effect of non-permissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T cell depletion
artículo científico publicado en 2018
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia
scientific article published on 01 June 1993
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia
artículo científico publicado en 2013
Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia
artículo científico publicado en 2011
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling
artículo científico publicado en 2002
Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations
artículo científico publicado en 1999
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
artículo científico publicado en 1993
Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis
scientific article published on 01 January 1990
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
artículo científico publicado en 2003
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome
artículo científico publicado en 1989
Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2007
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
artículo científico publicado en 2008
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation
scientific article published on 09 February 2020
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
artículo científico publicado en 2015
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy
scientific article published on 01 June 1997
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells
artículo científico publicado en 2018
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines
artículo científico publicado en 2012
Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation
artículo científico publicado en 2016
Epstein-Barr virus-associated, CD20- polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation
artículo científico publicado en 2004
Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation
artículo científico publicado el 1 de abril de 1994
Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation
artículo científico publicado en 1994
Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease
artículo científico publicado en 2017
Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement
artículo científico publicado en 2008
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
scientific article published on 01 September 2000
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.
artículo científico publicado en 2017
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission
artículo científico publicado en 2013
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
artículo científico publicado en 2006
Ex vivo expansion of umbilical cord blood
artículo científico publicado en 2005
Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma
artículo científico publicado en 2011
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
artículo científico publicado en 2005
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
artículo científico publicado en 2006
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results
artículo científico publicado en 2003
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.
artículo científico publicado en 2012
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim
artículo científico publicado en 1997
Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy
artículo científico publicado en 2002
Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients
artículo científico publicado en 2020
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
artículo científico publicado en 2009
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin
artículo científico publicado en 2013
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
artículo científico publicado en 2011
Fifty years of melphalan use in hematopoietic stem cell transplantation
artículo científico publicado en 2013
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
artículo científico publicado en 2010
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma
scientific article published on 01 June 2006
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
artículo científico publicado en 2018
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
artículo científico publicado en 2016
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia
⬇️
artículo científico publicado el 12 de octubre de 2010
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
artículo científico publicado en 2012
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience
artículo científico publicado en 2008
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma
artículo científico publicado en 2002
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir
artículo científico publicado en 1997
Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation
artículo científico publicado en 2018
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.
artículo científico publicado en 2017
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment
artículo científico publicado en 2013
Functional assessment and specific depletion of alloreactive human T cells using flow cytometry
scientific article published on 29 July 2004
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation
artículo científico publicado en 1996
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
artículo científico publicado en 2021
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial
scientific article published on 01 February 1993
Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients
artículo científico publicado en 1988
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
artículo científico publicado en 2016
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results
artículo científico publicado en 2011
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy
artículo científico publicado en 2020
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy
artículo científico publicado en 2021
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
artículo científico publicado en 2016
Genetic therapy of human neoplastic disease.
artículo científico publicado en 1993
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
scientific article published on 01 March 2020
Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers
artículo científico publicado en 2008
Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets
artículo científico publicado en 1994
Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning
artículo científico publicado en 1987
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results
scientific article published on 01 February 1989
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier
artículo científico publicado en 2004
Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
artículo científico publicado en 2006
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia
artículo científico publicado en 2007
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia
scientific article published on 01 September 1996
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality
artículo científico publicado en 1999
Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation
artículo científico publicado en 2000
Granulocyte colony-stimulating factor--primed allogeneic bone marrow transplants: capturing the advantages of blood stem cell transplants without increased risk of chronic graft-versus-host disease
artículo científico publicado en 2000
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation
artículo científico publicado en 2001
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants
artículo científico publicado en 1991
HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant
scientific article published on 23 January 2019
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.
artículo científico publicado en 1996
HLA-mismatched bone marrow transplantation in severe aplastic anemia
artículo científico publicado en 2017
Hairy-cell leukemia: biology and treatment
artículo científico publicado en 1986
Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.
artículo científico publicado en 2002
Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy
artículo científico publicado en 2015
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
artículo científico publicado en 2016
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
artículo científico publicado en 2017
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia
artículo científico publicado en 2016
Haploidentical Transplants for Patients with Graft Failure After the First Allograft
scientific article published on 29 June 2020
Haploidentical Transplants for Patients with Relapse After the First Allograft
artículo científico publicado en 2020
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
artículo científico publicado en 2015
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation
artículo científico publicado en 2019
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning
artículo científico publicado en 2019
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
artículo científico publicado en 2000
Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion
artículo científico publicado en 1997
Hematologic malignancies and Li-Fraumeni syndrome
artículo científico publicado en 2019
Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China
artículo científico publicado en 2017
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
artículo científico publicado en 2015
Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative
artículo científico publicado en 2012
Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit
artículo científico publicado en 2013
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy
artículo científico publicado en 2010
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma
artículo científico publicado en 1999
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia
artículo científico publicado en 1998
Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review
artículo científico
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate
artículo científico publicado en 1992
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters
artículo científico publicado en 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type
artículo científico publicado en 2010
Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.
artículo científico publicado en 2015
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells
scientific article published on 01 March 2002
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment
artículo científico publicado en 2009
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes
artículo científico publicado en 2003
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer
artículo científico publicado en 2000
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia
artículo científico publicado en 1994
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation
artículo científico publicado en 2011
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation
artículo científico publicado en 2009
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation
artículo científico publicado en 2007
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
artículo científico publicado en 2008
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
artículo científico publicado en 2006
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma
artículo científico publicado en 2013
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia
artículo científico publicado en 2001
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome
artículo científico publicado en 1998
High-dose chemotherapy with autologous stem cell support in patients with breast cancer
artículo científico publicado en 1998
High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends
artículo científico publicado en 2000
High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer.
artículo científico publicado en 1981
High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results
scientific article published on 01 June 1985
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
artículo científico publicado en 2017
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer
artículo científico publicado en 2000
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies
artículo científico publicado en 2012
High-dose melphalan allows durable engraftment of allogeneic bone marrow
artículo científico publicado en 1995
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant
scientific article published on 01 August 2000
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma
artículo científico publicado en 2006
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis
artículo científico publicado en 2015
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma
artículo científico publicado en 2004
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer
artículo científico publicado en 2001
High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes
scientific article published on 22 July 2018
Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis
artículo científico publicado en 2015
Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry
scientific article published on 01 November 2004
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease
artículo científico publicado en 2017
How I transplant a patient with a history of invasive fungal disease
artículo científico publicado en 2020
How does bone-marrow transplantation cure leukaemia?
artículo científico publicado en 1984
Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity
artículo científico publicado en 1998
Humoral stimulation of hemopoietic progenitors from human fetal liver
artículo científico publicado el 1 de enero de 1982
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma
artículo científico publicado en 1998
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial
artículo científico publicado en 2020
Hyperacute GVHD: risk factors, outcomes, and clinical implications
artículo científico publicado en 2007
Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment
⬇️
artículo científico publicado el 15 de septiembre de 1995
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation
artículo científico publicado en 2016
IMPS-04TUNING SENSITIVITY OF CHIMERIC ANTIGEN RECEPTOR TO EGFR DENSITY LIMITS RECOGNITION OF NORMAL TISSUE WHILE MAINTAINING POTENT ANTI-TUMOR ACTIVITY.
artículo científico publicado en 2015
Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial
artículo científico publicado en 2016
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
artículo científico publicado en 2015
Identical-twin bone marrow transplants for leukemia.
artículo científico publicado en 1994
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype.
artículo científico publicado en 2010
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer
artículo científico publicado en 2003
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity
scientific article published on 01 April 2020
Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography
artículo científico publicado en 2016
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
artículo científico publicado en 2002
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
artículo científico publicado en 2014
Immunologic defects in young male patients with hepatitis-associated aplastic anemia
artículo científico publicado en 1984
Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells
artículo científico publicado en 1988
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
artículo científico publicado en 2019
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma
scientific article published on 11 February 2019
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes
artículo científico publicado en 2017
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
artículo científico publicado en 2017
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2018
Impact of TKI maintenance post-allogeneic transplant in Philadelphia positive acute lymphoblastic leukemia
artículo científico publicado en 2020
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome
artículo científico publicado en 2018
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
artículo científico publicado en 2013
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma
article by R Alexanian et al published May 2001 in Bone Marrow Transplantation
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2006
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation
artículo científico publicado en 2020
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
artículo científico publicado en 2009
Impact of high-dose chemotherapy on peripheral T-cell lymphomas
artículo científico publicado en 2001
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
artículo científico publicado en 2011
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2005
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
artículo científico publicado en 2009
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies
scientific article published on 01 November 1996
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia
artículo científico publicado en 2008
Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.
artículo científico publicado en 2013
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma
artículo científico publicado en 2009
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant
artículo científico publicado en 2000
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.
artículo científico publicado en 2012
Improved survival following bone marrow transplantation for aplastic anaemia
⬇️
artículo científico publicado el 1 de agosto de 1983
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
artículo científico publicado en 2012
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade
artículo científico publicado en 2015
In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin
artículo científico publicado en 1991
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation
artículo científico publicado en 2013
Increased incidence of fractures in recipients of hematopoietic stem-cell transplantation.
artículo científico publicado en 2015
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time
artículo científico publicado en 2014
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
artículo científico publicado en 2015
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy
artículo científico publicado en 2020
Individual physician practice variation in hematopoietic cell transplantation
artículo científico publicado en 2008
Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005
artículo científico publicado en 2007
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention
artículo científico publicado en 2009
Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation
artículo científico publicado en 2011
Infectious complications of bone marrow transplantation
artículo científico publicado el 1 de marzo de 1984
Influenza A virus infections among hospitalized adult bone marrow transplant recipients.
artículo científico publicado en 1994
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.
artículo científico publicado en 2012
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2018
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
artículo científico publicado en 2012
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
artículo científico publicado en 2017
Intensive Sequential Therapy for VAD-Resistant Multiple Myeloma
artículo científico publicado en 1994
Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.
artículo científico publicado en 1994
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma
artículo científico publicado en 1999
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer
artículo científico publicado en 2000
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
artículo científico publicado en 2009
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma
artículo científico publicado en 1999
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL
artículo científico publicado en 2012
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
artículo científico publicado en 2017
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit
artículo científico publicado en 2003
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
artículo científico publicado en 2010
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation
artículo científico publicado en 1987
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients
artículo científico publicado en 1993
Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial
scientific article published on 01 March 1984
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-
artículo científico publicado en 2002
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Is there an expiration date for a cord blood unit in storage?
artículo científico publicado en 2014
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
scientific article published on 01 February 2020
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.
artículo científico publicado en 2013
KIR gene haplotype: an independent predictor of clinical outcome in MDS patients
artículo científico publicado en 2016
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
artículo científico publicado en 2020
Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation
scientific article published on 01 May 1994
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation
artículo científico publicado en 2005
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients
artículo científico publicado en 1999
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
artículo científico publicado en 2012
Leptomeningeal toxoplasmosis after allogeneic marrow transplantation. Case report and review of the literature
artículo científico publicado en 1993
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
artículo científico publicado en 2014
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
artículo científico publicado en 2008
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation
artículo científico publicado en 2015
Leukemia relapse after allogeneic bone marrow transplantation: a review
scientific article published on 01 December 1994
Limited value of myeloablative therapy for late multiple myeloma.
artículo científico publicado en 1994
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
artículo científico publicado en 2016
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation
artículo científico publicado en 2001
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome
artículo científico publicado en 2018
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
artículo científico publicado en 2015
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
artículo científico publicado en 2003
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes
artículo científico publicado en 2011
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia
artículo científico publicado en 2007
Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score
artículo científico publicado en 2003
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development
artículo científico publicado en 2002
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival
artículo científico publicado en 2017
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis
artículo científico publicado en 2008
Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation
artículo científico publicado en 2002
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients
scientific article published on 01 January 1999
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation
scientific article published on 01 January 1995
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
artículo científico publicado en 2006
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR
artículo científico publicado en 2011
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib
scientific article published on 02 September 2018
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
artículo científico publicado en 2020
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
artículo científico publicado en 2003
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy
artículo científico publicado en 2014
Lovastatin Inhibits T-cell Proliferation While Preserving the Cytolytic Function of EBV, CMV, and MART-1-specific CTLs
⬇️
artículo científico publicado el 1 de noviembre de 2010
Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
artículo científico publicado en 2005
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics
artículo científico publicado en 2004
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia
artículo científico publicado en 2009
Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
artículo científico publicado en 1993
Lymphocyte Recovery Predicts Outcomes in Cord Blood and T Cell–Depleted Haploidentical Stem Cell Transplantation
⬇️
artículo científico publicado el 30 de noviembre de 2010
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.
artículo científico publicado en 2015
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study
artículo científico publicado en 2010
Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index
artículo científico publicado en 2017
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes
artículo científico publicado en 2017
Management of cancer treatment-related diarrhea. Issues and therapeutic strategies
artículo científico publicado en 2000
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect
artículo científico publicado en 1997
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells
artículo científico publicado en 2013
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy
artículo científico publicado en 1999
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report
artículo científico publicado en 2004
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
artículo científico publicado en 2009
Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implications
artículo científico publicado en 2013
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
artículo científico publicado en 2001
Melphalan based autologous transplant in octogenarian multiple myeloma patients
article
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells
artículo científico publicado en 2012
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
scientific article published on 01 February 1993
Microbial contamination of hematopoietic progenitor cell products: clinical outcome
artículo científico publicado en 2007
Mini-allografts: ongoing trials in humans
artículo científico publicado en 2000
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia
artículo científico publicado en 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
artículo científico publicado en 2015
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
scientific article published on 11 July 2019
Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors
artículo científico publicado en 1997
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2009
Molecular approaches to the diagnosis and treatment of cancer.
artículo científico publicado en 1993
Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation
artículo científico publicado en 2020
Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation
artículo científico publicado en 1985
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients
artículo científico publicado en 1984
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes
artículo científico publicado en 2016
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning
artículo científico publicado en 2014
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation
artículo científico publicado en 2013
Myasthenia gravis and polymyositis in a dog following fetal hematopoietic cell transplantation
scientific article published on 01 January 1986
Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial
artículo científico publicado en 2019
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life
artículo científico publicado en 2011
Myeloablative therapy for primary resistant multiple myeloma.
artículo científico publicado en 1995
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy
scientific article published on 01 October 2019
NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation
artículo científico publicado en 2012
National Marrow Donor Program: progress and challenges
artículo científico publicado en 1993
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2007
Neurocognitive deficits in older patients with cancer.
artículo científico publicado en 2018
Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin
artículo científico publicado en 1996
Non myeloablative "mini transplants".
artículo científico publicado en 1999
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.
artículo científico publicado en 2002
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
artículo científico publicado en 2001
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival
artículo científico publicado en 2004
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma
artículo científico publicado en 2003
Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes
artículo científico publicado en 2002
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
scientific article published on 15 April 2004
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
artículo científico publicado en 2004
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.
artículo científico publicado en 2009
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma
artículo científico publicado en 2012
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome
artículo científico publicado en 2011
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
artículo científico publicado en 2012
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
artículo científico publicado en 2001
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
artículo científico publicado en 2003
Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus
scientific article published on 01 December 2004
Nonmyeloablative stem cell transplantation for chronic myeloid leukemia
artículo científico publicado en 2004
Nonmyeloablative stem cell transplantation for lymphoma
artículo científico publicado en 2004
Norfloxacin for prevention of bacterial infections in granulocytopenic patients
scientific article published on 01 June 1987
Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
scientific article published on 01 May 1986
Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients
artículo científico publicado en 1997
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation
scientific article published on 10 September 2019
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity
scientific article published on 01 July 2007
Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
artículo científico publicado en 1990
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
artículo científico publicado en 2008
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
artículo científico publicado en 2004
Open lung biopsy in bone marrow transplant recipients has a poor diagnostic yield for a specific diagnosis
scientific article published on 01 June 2002
Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation
artículo científico publicado en 2015
Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates
artículo científico publicado en 2014
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
artículo científico publicado en 2013
Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection
artículo científico publicado en 2007
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis
artículo científico publicado en 2019
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
artículo científico publicado en 2015
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
artículo científico publicado en 2015
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2016
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction
artículo científico publicado en 2009
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
artículo científico publicado en 2017
Outcome of bone marrow transplantation patients requiring mechanical ventilation
artículo científico publicado en 2000
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement
artículo científico publicado en 2016
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
artículo científico publicado en 2015
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
artículo científico publicado en 2004
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation
artículo científico publicado en 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant
⬇️
artículo científico publicado en 2016
Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2013
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
artículo científico publicado en 2015
Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.
artículo científico publicado en 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure
artículo científico publicado en 2015
Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci
⬇️
artículo científico publicado el 20 de octubre de 2010
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
artículo científico publicado en 2013
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years
artículo científico publicado en 2019
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia
scientific article published on 26 June 2019
Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy
artículo científico publicado en 2004
Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience
artículo científico publicado en 2017
Outcomes of patients treated and one human leukocyte antigen-mismatched related compared with matched unrelated donors
artículo científico publicado en 2011
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia
artículo científico publicado en 2012
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
scientific article published on 01 June 2007
Overall survival in older patients with cancer
scientific article published on 22 September 2018
PET imaging of T cells derived from umbilical cord blood
artículo científico publicado en 2008
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
artículo científico publicado en 2016
Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2013
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
artículo científico publicado en 2018
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma
artículo científico publicado en 2017
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes.
artículo científico publicado en 2015
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
artículo científico publicado en 2017
Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation
artículo científico
Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts
artículo científico publicado en 1996
Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections
scientific article published on 01 February 1997
Peripheral blood stem cell apheresis in normal donors: the neglected side
artículo científico publicado en 1996
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases
artículo científico publicado en 2001
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule
artículo científico publicado en 2007
Phase 1 clinical trial using mbIL21 ex-vivo expanded donor-derived NK cells after haploidentical transplantation
artículo científico publicado en 2017
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
artículo científico publicado en 2016
Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer.
artículo científico publicado en 1997
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
artículo científico publicado en 2017
Phase I study of high-dose mitomycin with autologous bone marrow support
scientific article published on 01 February 1982
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue
scientific article published on 01 February 1997
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
artículo científico publicado en 2016
Phase I/II Study of Dasatinib in Combination with Decitabine in Patients with Accelerated or Blast Phase Chronic Myeloid Leukemia
artículo científico publicado en 2020
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer
artículo científico publicado en 1997
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome
artículo científico publicado en 2007
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma
artículo científico publicado en 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O
article
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
artículo científico publicado en 2015
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
artículo científico publicado en 2018
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival
artículo científico publicado en 2001
Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia.
artículo científico publicado en 1987
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma
artículo científico publicado en 2004
Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients
artículo científico publicado en 2012
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies
artículo científico publicado en 2006
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma
artículo científico publicado en 2010
Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
artículo científico publicado en 2014
Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer
artículo científico publicado en 2009
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation
scientific article published on 18 October 2018
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.
artículo científico publicado en 2011
Pneumococcal vaccination of recipients of bone marrow transplants
artículo científico publicado en 1983
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma
artículo científico publicado en 2009
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients
artículo científico publicado en 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
artículo científico publicado en 2016
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors
scientific article published on 03 March 2020
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia
artículo científico publicado en 2016
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection
artículo científico publicado en 2003
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.
artículo científico publicado en 2017
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.
artículo científico publicado en 2016
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
artículo científico publicado en 2012
Pretransplant chest computed tomography screening in asymptomatic patients with leukemia and myelodysplastic syndrome
artículo científico publicado en 2016
Prevention of CMV Reactivation in Haploidentical Stem Cell Transplantation
artículo científico publicado en 2017
Prevention of graft rejection following bone marrow transplantation
artículo científico publicado en 1981
Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients
scientific article published on 01 December 1995
Primary Systemic Amyloid Light Chain Amyloidosis Decompensating After Filgrastim-Induced Mobilization and Stem-Cell Collection
⬇️
artículo científico publicado el 8 de noviembre de 2010
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
artículo científico publicado en 2018
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation
artículo científico publicado en 2006
Principles of bone marrow processing and progenitor cell/mononuclear cell concentrate collection in a continuous flow blood cell separation system
scientific article published on 01 August 1995
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium - HAPLO2016, San Diego, California, December 1, 2016.
artículo científico publicado en 2018
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
artículo científico publicado en 2016
Prognostic Index for Critically Ill Allogeneic Transplantation Patients.
artículo científico publicado en 2017
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
artículo científico publicado en 2012
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
artículo científico publicado en 2004
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
artículo científico publicado en 2005
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
scientific article published on 16 May 2018
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease
artículo científico publicado en 2016
Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
artículo científico publicado en 2016
Prognostic value of cytogenetics in multiple myeloma
scientific article published on 01 April 1998
Prognostic value of response after upfront therapy for acute GVHD
⬇️
artículo científico publicado el 7 de marzo de 2011
Progress in haploidentical stem cell transplantation
artículo científico publicado en 2011
Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia
artículo científico publicado en 1996
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer
scientific article published on 18 May 2009
Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy
⬇️
artículo científico publicado el 21 de abril de 1984
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma
artículo científico publicado en 2016
Prophylactic use of immunoglobulin in bone marrow transplantation
scientific article published on 01 January 1986
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
artículo científico publicado en 2010
Prophylaxis of infection in bone marrow transplants
artículo científico publicado en 1988
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
artículo científico publicado en 2006
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation
scientific article published on 21 May 2019
Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients
artículo científico publicado en 2018
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia
artículo científico publicado en 2016
Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation
artículo científico publicado en 1999
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia
artículo científico publicado en 2009
Radiation accidents and nuclear energy: medical consequences and therapy
artículo científico publicado en 1988
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant
artículo científico publicado en 2011
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years
scientific article published on 01 June 2006
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
scientific article published on 01 February 2000
Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system
scientific article published on 01 October 1996
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors
artículo científico publicado en 2003
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant
artículo científico publicado en 2009
Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation
artículo científico publicado en 2004
Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time
artículo científico publicado en 2009
Recent advances in the application of gene therapy to human disease
artículo científico publicado en 1995
Recombinant alpha-2-interferon for hairy cell leukemia
artículo científico publicado en 1985
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis
artículo científico publicado en 2006
Recombinant human thrombopoietin clinical development
artículo científico publicado en 1998
Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer
artículo científico publicado en 1988
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
artículo científico publicado en 2006
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
artículo científico publicado en 2016
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor
artículo científico publicado en 2016
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system
artículo científico publicado en 2008
Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.
artículo científico publicado en 2012
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?
scientific article published on 01 June 2006
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
artículo científico publicado en 2018
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma
artículo científico publicado en 2010
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen
scientific article published on 01 May 2005
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years
artículo científico publicado en 2003
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
artículo científico publicado en 2012
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
artículo científico publicado en 2009
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia
artículo científico publicado en 2009
Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review
artículo científico publicado en 1994
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD
artículo científico publicado en 2014
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect
artículo científico publicado en 1999
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy
artículo científico publicado en 1999
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Cente
artículo científico publicado en 2018
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation
artículo científico publicado en 2017
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature
artículo científico publicado en 1997
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.
artículo científico publicado en 2011
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells
artículo científico publicado en 1998
Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
scientific article published on 06 January 2010
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients
artículo científico publicado en 1996
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins
artículo científico publicado en 2001
Respiratory syncytial virus infections in children with cancer
artículo científico publicado en 2014
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
artículo científico publicado en 2000
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center
artículo científico publicado en 2006
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
artículo científico publicado en 2016
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes
artículo científico publicado en 2007
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations
artículo científico publicado en 2010
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia
artículo científico publicado en 2013
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.
artículo científico publicado en 2018
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience
scientific article published on 01 May 1996
Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia
scientific article published on 01 February 1991
Retrospective analysis of weekly intravenous immunoglobulin prophylaxis versus intravenous immunoglobulin by IgG level monitoring in hematopoietic stem cell transplant recipients
scientific article published on 12 November 2011
Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement
artículo científico publicado en 2011
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies
artículo científico publicado en 2007
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
artículo científico publicado en 1999
Risk factors for falls in older patients with cancer.
artículo científico publicado en 2017
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
artículo científico publicado en 1996
Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma
artículo científico publicado en 2006
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma
artículo científico publicado en 2002
Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT
scientific article published on 17 March 2008
Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia.
artículo científico publicado en 2005
Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants
artículo científico publicado el 1 de enero de 1984
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation
artículo científico publicado en 2000
Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells
artículo científico publicado en 2016
Romidepsin targets multiple survival signaling pathways in malignant T cells
artículo científico publicado en 2015
Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation
artículo científico publicado en 2013
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation
artículo científico publicado en 1997
Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients
artículo científico publicado en 1983
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial
artículo científico publicado en 2017
Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation
artículo científico publicado en 2005
Second HLA-identical sibling transplants for leukemia recurrence
artículo científico publicado el 1 de abril de 1992
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma
artículo científico publicado en 2006
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant
artículo científico publicado en 2004
Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation
artículo científico publicado en 1989
Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation
artículo científico publicado en 1990
Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia
artículo científico publicado el 1 de enero de 1992
Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation
artículo científico publicado en 2017
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma
artículo científico publicado en 2014
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?
⬇️
artículo científico publicado el 15 de mayo de 1992
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes
artículo científico publicado en 2020
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission
artículo científico publicado en 2012
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial
artículo científico publicado en 2016
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.
artículo científico publicado en 2014
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
artículo científico publicado en 2005
Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
artículo científico publicado en 2015
Sleeping beauty system to redirect T-cell specificity for human applications
artículo científico publicado en 2013
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
artículo científico publicado en 2016
Status of high-dose chemotherapy for breast cancer: a review
artículo científico publicado en 2000
Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?
artículo científico publicado en 2004
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I.
artículo científico publicado en 2010
Stem cell transplantation outcomes in lymphoblastic lymphoma
artículo científico publicado en 2016
Stem-cell transplantation in T-cell non-Hodgkin's lymphomas
artículo científico publicado en 2011
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy
artículo científico publicado en 2006
Steroid-Refractory Acute GVHD: Predictors and Outcomes.
artículo científico publicado en 2011
Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005
artículo científico publicado en 2007
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation
artículo científico publicado en 2006
Studies of decitabine with allogeneic progenitor cell transplantation
artículo científico publicado en 1997
Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome
artículo científico publicado en 2002
Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation.
artículo científico publicado en 1990
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells
artículo científico publicado en 2006
Survival and immune recovery in dogs following fetal liver transplantation.
artículo científico publicado en 1987
Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience
artículo científico publicado en 2005
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy
⬇️
artículo científico publicado el 1 de octubre de 1997
Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years
artículo científico publicado en 2020
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients
artículo científico publicado en 2015
Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells
artículo científico publicado en 2016
Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines
artículo científico publicado en 2014
Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FMS-like tyrosine kinase 3 internal tandem duplications-positive acute myeloid leukemia cells
artículo científico publicado en 2014
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines
artículo científico publicado en 2011
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells
artículo científico publicado en 2015
Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia
artículo científico publicado en 1999
T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation
artículo científico publicado en 1996
T-cell depletion of HLA-identical transplants in leukemia.
artículo científico publicado en 1991
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities
artículo científico publicado en 2000
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma
artículo científico publicado en 1992
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
artículo científico publicado en 1999
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
artículo científico publicado en 1996
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
artículo científico publicado en 2000
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.
artículo científico publicado en 2003
Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation
artículo científico
Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies
artículo científico publicado en 2015
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
artículo científico publicado en 2020
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
artículo científico publicado en 2016
The Clinical Impact of Time to Response in De Novo Accelerated-Phase Chronic Myeloid Leukemia
scientific article published on 17 June 2020
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes
artículo científico publicado en 2009
The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment
artículo científico
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
artículo científico publicado en 2017
The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer
artículo científico publicado en 1997
The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells
artículo científico publicado en 2002
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
artículo científico publicado en 2012
The choice of allogeneic or autologous hematopoietic transplantation for NHL.
artículo científico publicado en 2002
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation
artículo científico publicado en 2013
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
artículo científico publicado en 2015
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2014
The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes
artículo científico publicado en 2009
The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan
artículo científico publicado en 2014
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation
artículo científico publicado el 1 de junio de 1997
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis
artículo científico publicado en 2012
The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms
artículo científico publicado en 2008
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes
artículo científico publicado en 2010
The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation
artículo científico publicado en 2005
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
⬇️
artículo científico publicado el 8 de octubre de 2010
The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial
artículo científico publicado en 1991
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy
artículo científico publicado en 2004
Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress
artículo científico publicado en 2001
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia
artículo científico publicado en 1999
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia
artículo científico publicado en 2001
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity
article
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
artículo científico publicado en 2001
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
article by Joshua N Kellner et al published 2 November 2018 in Oncotarget
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
scientific article published on 14 July 2020
Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients
artículo científico publicado en 1989
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome
artículo científico publicado en 2010
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
artículo científico publicado en 2013
Toxicity of single daily dose gentamicin in stem cell transplantation
artículo científico publicado en 1999
Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients
scientific article published on 01 September 1998
Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis
scientific article published on 01 July 1996
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment
artículo científico publicado en 2007
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
artículo científico publicado en 1998
Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow
artículo científico publicado el 1 de mayo de 1984
Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation
artículo científico publicado en 1985
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial
artículo científico publicado en 2008
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
scientific article published on 05 July 2007
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib
artículo científico publicado en 2011
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
artículo científico publicado en 2003
Treatment of acute myelogenous leukemia in the elderly
artículo científico
Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy
scientific article published on 01 March 1985
Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation
artículo científico publicado en 1987
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors
scientific article published on 01 September 1994
Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody
scientific article published on 01 January 1984
Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial
artículo científico publicado en 1986
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
artículo científico publicado en 2007
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2.
artículo científico publicado en 1995
Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor
scientific article published on 01 February 1989
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab
artículo científico publicado en 2003
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia
artículo científico publicado en 2015
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.
artículo científico publicado en 2004
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
artículo científico publicado en 2015
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase
artículo científico publicado en 2013
Umbilical cord blood-derived cells for tissue repair
artículo científico publicado en 2005
Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission
⬇️
artículo científico publicado el 16 de noviembre de 2010
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes
artículo científico publicado en 2009
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program
artículo científico publicado en 2000
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant
⬇️
artículo científico publicado el 1 de diciembre de 2003
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy
artículo científico publicado en 1986
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
artículo científico publicado en 2020
Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey
scientific article published on 01 January 1993
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia
scientific article published on 01 February 1997
Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases
scientific article published on 01 January 1999
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies
⬇️
artículo científico publicado el 1 de noviembre de 1997
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
artículo científico publicado en 1996
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.
artículo científico publicado en 1994
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization
artículo científico publicado en 2002
Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of Medicine
artículo científico publicado en 1993
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia
artículo científico publicado en 1997
Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma
artículo científico publicado en 2017
Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation
artículo científico publicado en 2009
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-transplant Survival Prediction in Patients with Hematologic Malignancies
artículo científico publicado en 2020
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
artículo científico publicado en 2013
Variation in supportive care practices in hematopoietic cell transplantation
artículo científico publicado en 2008
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
artículo científico publicado en 2015
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review
artículo científico publicado en 2003
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
artículo científico publicado en 2013
With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially?
artículo científico publicado en 1995
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
artículo científico publicado en 2007
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases
artículo científico publicado en 2005
[Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation]
scientific article published on 01 November 1985
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies
artículo científico publicado en 2010